How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...

Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, today announced that its Board ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...

We recently published 10 Big Names Beating Wall Street at its Own Game. Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is one of the best performers on Monday. Recursion Pharmaceuticals soared by 13.99 ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...

Bullish option flow detected in Recursion Pharmaceuticals (RXRX) with 35,100 calls trading, 5x expected, and implied vol increasing almost 42 points to 161.96%. 10/24 weekly 7 calls and 10/24 weekly 7 ...

Key data is currently not available. Data Disclaimer: The Nasdaq Indices and the Major Indices are delayed at least 1 minute. *Data is provided by Barchart.com. Data reflects weightings calculated at ...

My son Sam, as some of you know, is an accomplished pianist and composer here in DC. [his website's here] He and Ralitza Patcheva, a close friend and colleague (and masterful Bach interpreter), have ...

PETALING JAYA: JS Solar Holding Bhd is seeking to list on the ACE Market of Bursa Malaysia, according to its draft prospectus. The group is mainly involved in the provision of engineering, procurement ...